Heart Failure Is Not a Death Sentence: Symptoms, Types and 2026 Treatments
Dr.
Alo breaks down what heart failure actually is, the critical difference between HFrEF and HFpEF, and the easy to miss symptoms that send people to the ER. He then walks through the 2026 treatment landscape, including the four pillar guideline directed therapy, new SGLT2 inhibitor data, and a major update on mineralocorticoid receptor antagonists that most patients are still not getting.
Questions this episode answers:
What is the difference between HFrEF and HFpEF?
What are the early warning signs of heart failure?
Is heart failure a death sentence?
What medications treat heart failure in 2026?
What tests diagnose heart failure?
Why are SGLT2 inhibitors used for heart failure?
Keywords: heart failure, hfref, hfpef, congestive heart failure, ejection fraction, sglt2 inhibitors, guideline directed medical therapy, arni sacubitril valsartan, mineralocorticoid receptor antagonist, cardiologist advice, heart failure symptoms, heart failure treatment
This episode is for education only and is not medical advice. Talk to your own clinician about your own situation.
#heart #cardiology #drAlo #heartfailure #hfpef #hfref #cardiachealth
